John Martin Sowerby, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Proteins | 1 | 2017 | 1135 | 0.450 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2213 | 0.340 |
Why?
|
| Neutrophils | 2 | 2017 | 3865 | 0.280 |
Why?
|
| Immune System | 2 | 2021 | 819 | 0.250 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2022 | 47 | 0.240 |
Why?
|
| Germinal Center | 2 | 2020 | 364 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 312 | 0.190 |
Why?
|
| Gray Platelet Syndrome | 1 | 2017 | 7 | 0.170 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4925 | 0.170 |
Why?
|
| Respiratory Burst | 1 | 2017 | 138 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2020 | 597 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2019 | 626 | 0.140 |
Why?
|
| Phagocytes | 1 | 2017 | 303 | 0.140 |
Why?
|
| Cytosol | 1 | 2017 | 938 | 0.130 |
Why?
|
| Mutation | 2 | 2022 | 29242 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 1694 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1937 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2019 | 2340 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1393 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2137 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 1370 | 0.090 |
Why?
|
| Mycobacterium ulcerans | 1 | 2007 | 9 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2017 | 2481 | 0.080 |
Why?
|
| Skin Ulcer | 1 | 2007 | 125 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2020 | 15286 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11749 | 0.070 |
Why?
|
| Autoimmunity | 2 | 2022 | 1329 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10858 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 23985 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2020 | 11982 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 1821 | 0.050 |
Why?
|
| Phenotype | 1 | 2017 | 16295 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 8101 | 0.050 |
Why?
|
| Mice | 4 | 2020 | 80950 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2011 | 2277 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 4282 | 0.040 |
Why?
|
| Cytochrome b Group | 1 | 2017 | 57 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2020 | 579 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 597 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 581 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2020 | 1435 | 0.040 |
Why?
|
| Neoplasms | 1 | 2022 | 20421 | 0.030 |
Why?
|
| Animals | 4 | 2020 | 170647 | 0.030 |
Why?
|
| Pedigree | 1 | 2021 | 4720 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 1729 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 4012 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2011 | 126 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 1596 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 1202 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 7123 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5995 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 7071 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 6185 | 0.020 |
Why?
|
| Victoria | 1 | 2007 | 113 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4334 | 0.020 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2007 | 67 | 0.020 |
Why?
|
| Humans | 7 | 2022 | 709431 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7214 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3832 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 2929 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4351 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9941 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 20303 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10475 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21874 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 41195 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2511 | 0.010 |
Why?
|
| Macrophages | 1 | 2017 | 5774 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 615 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2683 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13668 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 23044 | 0.010 |
Why?
|
| Child | 2 | 2021 | 73998 | 0.010 |
Why?
|
| Male | 4 | 2021 | 351848 | 0.010 |
Why?
|
| Female | 4 | 2021 | 377269 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6583 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8941 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 29148 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 50734 | 0.000 |
Why?
|
| Adult | 2 | 2011 | 212298 | 0.000 |
Why?
|
| Middle Aged | 2 | 2011 | 215428 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 58752 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 71151 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 85327 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 162592 | 0.000 |
Why?
|